Recent Posts
- EFFECTS OF ALT 801, A GLP 1 AND GLUCAGON RECEPTOR DUAL AGONIST, IN A TRANSLATIONAL MOUSE MODEL OF NON ALCOHOLIC STEATOHEPATITIS
- DESIGN AND CHARACTERIZATION OF A SURFACTANT-CONJUGATED, LONG-ACTING, BALANCED GLP-1/GLUCAGON RECEPTOR DUAL AGONIST.
- SURFACTANT-MODIFIED PARATHYROID HORMONE FRAGMENTS WITH HIGH POTENCY AND PROLONGED ACTION: STRUCTURE-INFORMED DESIGN USING GLYCOLIPID SURFACTANT CONJUGATION
- PEPTIDE DEVELOPMENT GOES VIRTUAL
- VELOCITY PHARMACEUTICAL DEVELOPMENT ANNOUNCES CLINICAL DEVELOPMENT AGREEMENT
